Hypertensive Retinopathy

Overview


Plain-Language Overview

Hypertensive Retinopathy is a condition that affects the blood vessels in the eyes due to high blood pressure. It involves damage to the small arteries and veins in the retina, which is the light-sensitive tissue at the back of the eye. This damage can cause changes in vision and may lead to vision loss if severe. The condition reflects the impact of high blood pressure on the body's circulatory system, particularly the delicate vessels in the eye. Early signs include blurred vision and sometimes headaches. Monitoring eye health is important because the retina can reveal the severity of hypertension and its effects on other organs.

Clinical Definition

Hypertensive Retinopathy is a microvascular complication characterized by structural and functional changes in the retinal arterioles caused by chronic or acute elevations in systemic blood pressure. The core pathology involves arteriolar narrowing, arteriovenous nicking, and damage to the retinal capillaries leading to exudates, hemorrhages, and in severe cases, optic disc edema. It is primarily caused by sustained hypertension that induces endothelial dysfunction, increased vascular permeability, and ischemic injury to retinal tissue. Clinically, it serves as a window to systemic vascular damage and is associated with increased risk of stroke, myocardial infarction, and renal disease. The severity of hypertensive retinopathy correlates with the degree and duration of hypertension and can be classified into mild, moderate, and malignant forms based on retinal findings.

Inciting Event

Locked content.

Latency Period

Locked content.

Diagnostic Delay

Locked content.

Clinical Presentation


Signs & Symptoms

Locked content.

History of Present Illness

Locked content.

Past Medical History

Locked content.

Family History

Locked content.

Physical Exam Findings

Locked content.

Diagnostic Workup


Diagnostic Criteria

Locked content.

Pathophysiology


Key Mechanisms

Locked content.

Organs

Locked content.

Tissues

Locked content.

Cells

Locked content.

Chemical Mediators

Locked content.

Treatments


Pharmacological Treatments

Locked content.

Non-pharmacological Treatments

Locked content.

Prevention


Pharmacological Prevention

Locked content.

Non-pharmacological Prevention

Locked content.

Outcome & Complications


Complications

Locked content.

Short-term Sequelae

Locked content.

Long-term Sequelae

Locked content.

Differential Diagnoses


Differentials

Locked content.

Medical Disclaimer: The content on this site is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. If you think you may be experiencing a medical emergency, call 911 or your local emergency number immediately. Always consult a licensed healthcare professional with questions about a medical condition.

Artificial Intelligence Use: Portions of this site's content were generated or assisted by AI. All material has been reviewed by Erik Romano, MD, however, errors or omissions may still occur.

USMLE® is a registered trademark of the Federation of State Medical Boards (FSMB) and the National Board of Medical Examiners (NBME). Doctogenic and Roscoe & Romano are not affiliated with, sponsored by, or endorsed by the USMLE, FSMB, or NBME. Neither FSMB nor NBME has reviewed or approved this content. “USMLE Step 1” and “USMLE Step 2 CK” are used only to identify the relevant examinations.